We are live on ! Find out more
C

Cerebellum Portfolio holdings

AUM $21.5M
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$59.7M
AUM Growth
-$18.3M
Cap. Flow
-$18.3M
Cap. Flow %
-30.61%
Top 10 Hldgs %
3.14%
Holding
576
New
140
Increased
78
Reduced
180
Closed
172

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$347K
2
LRCX icon
Lam Research
LRCX
+$206K
3
STLA icon
Stellantis
STLA
+$203K
4
NBR icon
Nabors Industries
NBR
+$203K
5
TOL icon
Toll Brothers
TOL
+$202K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.13%
2 Technology 15.51%
3 Industrials 14.6%
4 Financials 13.81%
5 Energy 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZR
576
DELISTED
Caesars Entertainment Corporation
CZR
-7,983
Closed -$90K

Similar funds

Cerebellum's Q2 2018 Portfolio in Review

As of Q2 2018, Cerebellum held 576 positions worth $59.7M, down 24% from $78M the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.

Cerebellum withdrew a net $18.3M in Q2 2018, closing 172 positions and reducing 180 holdings. Its most notable exit was Monsanto Co, an estimated $283K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Cerebellum opened a new position in Amgen worth $167K.

  • Cerebellum's largest Q2 2018 buy was Amgen: 1,961 shares worth $167K.
  • Cerebellum added most to Keurig Dr Pepper in Q2 2018, an estimated $184K increase.
  • Cerebellum's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.4M.
  • Cerebellum fully exited Monsanto Co in Q2 2018, selling an estimated $283K.
  • Cerebellum's ten largest holdings make up 3.1% of its $59.7M portfolio in Q2 2018.
  • Cerebellum opened 140 new positions and closed 172 in Q2 2018.
  • Cerebellum's portfolio value fell 24% quarter-over-quarter to $59.7M.

Based on Cerebellum's 13F filing for Q2 2018, filed 5 Jul 2018.